Diseases & Disorders
(G22Z)
IRS Verified
DX Registered
990 on File
MARTIN CENTER INC
Financial strength (30%)
69/100
Reliability (20%)
55/100
Effectiveness (25%)
86/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
MCSCI exists to aid and enhance the lives of those affected by Sickle Cell and associated disorders by providing services, education and advocacy. We are committed to educating clients as well as community members by providing access to quality educational experiences.
Financial Overview — FY 2025
$878K
Total Revenue
$782K
Total Expenses
$718K
Net Assets
10
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
87.7%
Fundraising Efficiency
442.3%
Operating Reserve
11.02x
Liability-to-Asset
7.9%
Revenue Diversification
99.1%
Executive Compensation
$141K
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
87.7% | 83.5% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.2% | 10.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.1% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
442.3% | 15.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
11.0 mo | 11.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
7.9% | 0.6% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.1% | 93.4% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-8.9% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-1.7% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.9% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $878K | $782K | $718K | 87.7% | 10 |
| 2024 | $964K | $796K | $622K | 85.4% | 7 |
| 2023 | $851K | $832K | $455K | 85.5% | 7 |
| 2022 | $837K | $847K | N/A | — | 9 |
| 2021 | $797K | $716K | N/A | — | 9 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.